Addex Therapeutics (ADXN) Change in Net Loans (2017 - 2026)

Addex Therapeutics has disclosed Change in Net Loans across 9 years of filings, most recently posting $3553.9 for Q1 2026.

• In Q1 2026, Change in Net Loans rose 1062.42% year-over-year to $3553.9; the TTM figure through Mar 2026 stood at $939.53 (down 94.08% YoY), while the FY2024 annual figure was -$6420.1, down 348.86% from the prior year.
• Change in Net Loans came in at $3553.9 for Q1 2026 at Addex Therapeutics, up from -$369.27 in the prior quarter.
• In the past five years, Change in Net Loans ranged from a high of $18474.5 in Q3 2023 to a low of -$14037.9 in Q2 2023.
• Average Change in Net Loans over 5 years is $2091.8, with a median of -$369.27 recorded in 2025.
• Year-over-year, Change in Net Loans sank 368.9% in 2023 and surged 1062.42% in 2026.
• Over 5 years, Change in Net Loans stood at $5220.5 in 2022, then sank by 109.11% to -$475.74 in 2023, then tumbled by 271.91% to -$1769.4 in 2024, then soared by 79.13% to -$369.27 in 2025, then surged by 1062.42% to $3553.9 in 2026.
• Per Business Quant data, the three most recent Change in Net Loans figures were $3553.9 in Q1 2026, -$369.27 in Q1 2025, and -$1769.4 in Q4 2024.